Search Results 271-280 of 38930 for Two-phase

1. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. A Study to Evaluate the Safety, Effectiveness and Tolerability of APG-2575 in Patients with Waldenström Macroglobulinemia - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

4. A Phase 3 Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis - Mayo Clinic

   The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients ...

5. I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Study of E7386 in Participants With Selected Advanced Neoplasms - Mayo Clinic

   Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

7. Evanthia Galanis, M.D. - Mayo Clinic Faculty Profiles

   Galanis served as the principal investigator in multiple phase 1 and 2 immunovirotherapy trials for ovarian cancer, glioblastoma, renal cell carcinoma, ...

8. Cervical cancer - Symptoms and causes - Mayo Clinic

   Squamous cells are thin and flat. The boundary between the two types of cells is where most cervical cancers start. Cervical cancer begins when healthy cells in ...

9. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

10. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

    The purpose of this three-stage stage study is to identify the recommended phase 2 dose (RP2D) of STI-6129 by assessing the safety, preliminary effectiveness ...